Understanding how brain cells become overly active in Fragile X syndrome
Transcriptional Mechanism underlying Neuronal Hyperexcitability in FXS
This study is looking at how certain brain receptors might be causing increased activity in people with Fragile X syndrome, which can lead to symptoms like anxiety and seizures, and it hopes to find new ways to help manage these symptoms.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10746620 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that lead to increased neuronal activity in patients with Fragile X syndrome (FXS), which can cause symptoms like anxiety and seizures. The study focuses on the role of a specific receptor, Group 1 metabotropic glutamate receptors (Gp1 mGluRs), and how their activation affects brain cell behavior. By examining the tumor suppressor protein p53, the researchers aim to uncover how these interactions contribute to the hyperexcitability seen in FXS. The findings could lead to more targeted treatments for managing symptoms associated with this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Fragile X syndrome who experience symptoms related to neuronal hyperexcitability.
Not a fit: Patients without a diagnosis of Fragile X syndrome or those who do not exhibit symptoms of neuronal hyperexcitability may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that effectively reduce symptoms like anxiety and seizures in patients with Fragile X syndrome.
How similar studies have performed: Previous research has shown promising results in understanding neuronal excitability mechanisms in related conditions, suggesting that this approach may yield valuable insights.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Tsai, Nien-Pei — University of Illinois at Urbana-Champaign
- Study coordinator: Tsai, Nien-Pei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.